0B68 Waldman, Scott - Thomas Jefferson University - Thomas Jefferson University

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  2. Managing the innovation supply chain to maximize personalized medicine
  3. Antiobesity pharmacotherapy: New drugs and emerging targets
  4. Molecular insights provide the critical path to disease mitigation
  5. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer
  6. Advances in cancer immunotherapy
  7. Colorectal cancer immunotherapy
  8. Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis
  9. Molecular staging of node negative patients with colorectal cancer
  10. Systems approaches evolve clinical pharmacology
  11. New advances in models and strategies for developing anti-obesity drugs
  12. Systems-based discovery advances drug development
  13. GUCY2C: At the intersection of obesity and cancer
  14. Translational medicine individualizes healthcare discovery, development and delivery
  15. Obesity pharmacotherapy: What is next?
  16. Immunotherapeutic strategies to target prognostic and predictive markers of cancer
  17. Guanylyl cyclase C as a biomarker in colorectal cancer
  18. Advancing pharmacometrics and systems pharmacology
  19. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
  20. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer